Opportunity
Simpler Grants.gov #HT942526NFRPNFRASA
Neurofibromatosis Research Academy Scholar Award (FY26) – Early-Career Research Grant Opportunity
Posted
June 25, 2026
Respond By
September 22, 2026
Identifier
HT942526NFRPNFRASA
NAICS
541715
The Defense Health Agency Contracting Activity (DHACA) is announcing a grant opportunity for early-career researchers in neurofibromatosis through the FY26 Neurofibromatosis Research Academy – Scholar Award (NFRA-SA). - Government Buyer: - Defense Health Agency (DHA) - Sub-agency: Defense Health Agency Research and Development (DHA R&D) - Office: Defense Health Agency Contracting Activity (DHACA) - OEMs and Vendors: - No specific OEMs or vendors are mentioned, as this is a research grant opportunity. - Products/Services Requested: - Service: Neurofibromatosis Research Project Grant (NFRA-SA) - Supports early-career independent investigators (Scholars) conducting basic, translational, and/or clinical research in neurofibromatosis (NF1, NF2, and schwannomatosis) - Approximately 3 awards, each capped at $1.2 million, for a maximum of 4 years - Includes funding for research, travel, and collaboration activities - Unique or Notable Requirements: - Applicants must be within 10 years of completing their terminal degree - Each Scholar must designate a Career Guide (mentor); a secondary Career Guide is required if the primary is from a different institution - Scholars must commit significant effort to neurofibromatosis research and address at least one FY26 NFRP Area of Emphasis - Clinical trials are excluded from this award - Open to a wide range of eligible organizations, including domestic and foreign, for-profit and nonprofit entities
Description
The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy – Scholar Award (NFRA-SA) supports early-career independent investigators (Scholars) joining the Neurofibromatosis Research Academy to pursue a neurofibromatosis project that may include basic, translational, and/or clinical research. The research should address at least one of the FY26 NFRP Areas of Emphasis under the leadership of the NFRA Director and Deputy Director. The goal is to conduct innovative and impactful research in neurofibromatosis disorders while developing successful, highly productive researchers in a collaborative environment.